Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

The Medical News ·
Health & Medicine United Kingdom

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the International Society for Extracellular Vesicles. This validates the TS-EV platform for a new class of liquid biopsy: the multiomic disease…

Read original article on The Medical News →

Related news